Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Company Overview More
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
CEO: Lin M.B.A., Ph.D., Yu-Hsin
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Futubull > Quotes > BLTE Belite Bio > Detailed Quotes

BLTE Belite Bio

Watchlist
14.690+0.420+2.94%
Close 05/26 20:00 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
14.860
Open
14.860
Turnover
299.93K
Low
14.400
Pre Close
14.270
Volume
20.55K
Market Cap
353.96M
P/E(TTM)
Loss
52wk High
17.500
Shares
24.10M
P/E(Static)
Loss
52wk Low
8.800
Float Cap
88.14M
Bid/Ask %
33.33%
Historical High
17.500
Shs Float
6.00M
Volume Ratio
0.71
Historical Low
8.800
Dividend TTM
--
Div Yield TTM
--
P/B
-23.47
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.34%
Amplitude
3.22%
Avg Price
14.593
Lot Size
1
Float Cap
88.14M
Bid/Ask %
33.33%
Historical High
17.500
Shs Float
6.00M
Volume Ratio
0.71
Historical Low
8.800
Dividend TTM
--
P/B
-23.47
Dividend LFY
--
Turnover Ratio
0.34%
Amplitude
3.22%
Avg Price
14.593
Lot Size
1
Price Forecast

No Data

News

Comment

Back to the Top